Twenty-four hour rhythms of hypothalamic corticotropin-releasing hormone, thyrotropin-releasing hormone, growth hormone-releasing hormone and somatostatin in rats injected with freund’s adjuvant

NeuroSignals

Volumn 8, Issue 3, 1999, Pages 178-190

  Esquifino, Ana I ^a,b   Elena, Laura Selgas ^a,b   Arce, Vara Agustín ^a,b   Cardinali, Daniel P ^a,b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

CRH; Cyclosporine; Freund s adjuvant arthritis; GRH; Hypothalamus; Somatostatin; TRH

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CYCLOSPORIN; DRUG VEHICLE; FREUND ADJUVANT; GROWTH HORMONE RELEASING FACTOR; IMMUNOSUPPRESSIVE AGENT; PROTIRELIN; SOMATOSTATIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; HORMONE DETERMINATION; INFLAMMATION; LIGHT; MALE; MEDIAN EMINENCE; NONHUMAN; POSTERIOR HYPOTHALAMUS; RAT;

ANIMALS; CIRCADIAN RHYTHM; CORTICOTROPIN-RELEASING HORMONE; CYCLOSPORINE; FREUND'S ADJUVANT; GROWTH HORMONE-RELEASING HORMONE; HYPOTHALAMUS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MALE; RATS; RATS, WISTAR; SOMATOSTATIN; THYROTROPIN-RELEASING HORMONE;

ANIMALIA;

EID: 0032929189     PISSN: 1424862X     EISSN: 14248638     Source Type: Journal    
DOI: 10.1159/000014588     Document Type: Article

References (31)

1. Pearson CM: Development of arthritis, periarthritis and periostitis in rats given adjuvant. Proc Soc Exp Biol Med 1956;91:95-103.
2. Colpaert FC: Adjuvant arthritis in the rat as an animal model of chronic pain: Validation, time course and measurement; in Besson JM, Guilbaud G (eds): The Arthritic Rat as a Model of Chronic Clinical Pain. Amsterdam, Elsevier, 1988, pp 1-14.
3. Whitehouse MW: Adjuvant-in duced polyarthritis in rats; in Green-wald RA, Diamad HS (eds): Handbook of Animal Models for the Rheumatic Diseases. New York, CRC Press, 1988, pp 3-16.
4. Taurog JD, Sandberg GP, Maho-wald ML: The cellular basis of adjuvant arthritis. Cell Immunol 1983; 75:271-282.
5. Neidhart M, Fluckiger EW: Hyper-prolactinaemia in hypophysecto-mized or intact male rats and the development of adjuvant arthritis. Immunology 1992;77:449-455.
6. Selgas L, Arce A, Esquifino AI, Cardinali DP: Twenty-four hour rhythms of serum ACTH, prolactin, growth hormone and thyroid-stimulating hormone, and of median eminence norepinephrine, dopamine and serotonin, in rats injected with Freund’s adjuvant. Chronobiol Int 1997;14:253-265.
7. Neidhart M: Bromocriptine microcapsules inhibit ornithine decarboxylase activity induced by Freund’s complete adjuvant in lymphoid tissues of male rats. Endocrinology 1989;125:2846-2852.
8. Moreno ML, Villamla MA, Esquifino AI: Serum prolactin and luteinizing hormone levels and the activities of hypothalamic monoamine oxidase A and B and phenylethanol-amine-N-methyl transferase are changed during sexual maturation in male rats treated neonatally with melatonin. J Pineal Res 1992; 13: 167-173.
9. Hiestandt P, Mekler P: Mechanism of action: Cyclosporin- and prolactin-mediated control of immunity. Prog Allergy 1986;38:239-246.
10. Wilner ML, Ettenger RB, Koyle MA, Rosenthal J: The effect of hyperprolactinemia alone and in combination with cyclosporine on allograft rejection. Transplantation 1990;49:264-267.
11. Tamarit-Rodriguez J, Vara E, Ta-marit J: Antigenic specificity of a new and potent somatostatin antiserum. Horm Metabol Res 1985; 17: 623-625.
12. Vara E, Tamarit-Rodriguez J: Islet secretion of immunoreactive thyrotropin-releasing hormone and the ‘paracrine-like’ effects of its exogenous administration. Acta Endocrinol 1988;118:429-436.
13. Cardinali DP, Esquifino AI, Arce A, Vara E, Ariznavarreta C, Tres-guerres JAF: Changes in serum growth hormone and prolactin levels, and in hypothalamic growth hormone-releasing hormone, thyrotropin hormone-releasing hormone and somatostatin content after superior cervical sympathectomy in rats. Neuroendocrinology 1994;59:42-48.
14. Esquifino AI, Arce A, Villamia MA, Cardinali DP: Twenty-four hour rhythms of serum prolactin, growth hormone and luteinizing hormone levels, and of medial basal hypothalamic corticotropin-releasing hormone levels and dopamine and serotonin metabolism, in rats neonatally administered melatonin. J Pineal Res 1997;22:52-58.
15. Leal AM, Moreira AC: Feeding and the diurnal variation of the hypothalamic-pituitary-adrenal axis and its responses to CRH and ACTH in rats. Neuroendocrinology 1996;64: 14-19.
16. Szafarczyk A, Hery M, Laplante E, Ixart G, Assenmacher I, Kordon C: Temporal relationships between the circadian rhythmicity in plasma levels of pituitary hormones and in hypothalamic concentrations of releasing factors. Neuroendocrinology 1980;30:369-376.
17. Fishman AJ, Kastin A, Graf MV: Constant light and dark affect the circadian rhythm of hypothalamic-pituitary-adrenal axis. Neuroendocrinology 1988;47:308-316.
18. Kwak SP, Young EA, Morano I, Watson SJ, Akil H: Diurnal corticotropin-releasing hormone mRNA variation in the hypothalamus exhibits a rhythm distinct from that of plasma corticosterone. Neuroendocrinology 1992;55:74-83.
19. Kwak SP, Morano MI, Young EA, Watson SJ, Akil H: Diurnal CRH mRNA rhythm in the hypothalamus: Decreased expression in the evening is not dependent on endogenous glucocorticoids. Neuroendocrinology 1993;57:96-105.
20. Covarrubias L, Redondo JL, Vargas MA, Uribe RM, Mendez M, JosephBravo P, Charli JL: In vitro TRH release from hypothalamus slices varies during the diurnal cycle. Neu-rochem Res 1994;19:845-850.
21. De Souza CJ, Meier AH: Daily intervals of heat exposure alter the phase of the daily variation of plasma hormones in Holtzman rats. Am J Physiol 1993;265:R1115-R1120.
22. Marti O, Gavalda A, Jolin T, Armario A: Effect of regularity of exposure to chronic immobilization stress on the circadian pattern of pituitary hormones, growth hormone, and thyroid stimulating hormone in the adult male rat. Psychoneuroendocrinology 1993;18: 67-77.
23. Shinohara K, Isobe Y, Takeuchi J, Inouye ST: Circadian rhythms of so-matostatin-immunoreactivity in the suprachiasmatic nucleus of the rat. Neurosci Lett 1991;129:59-62.
24. Tanaka M, Okamura H, Matsuda T, Shigeyoshi Y, Hisa Y, Chihara K, Ibata Y: Somatostatin neurons form a distinct peptidergic neuronal group in the rat suprachiasmatic nucleus: A double labeling in situ hybridization study. Neurosci Lett 1996;215:119-122.
25. Nishiwaki T, Okamura H, Kane-masa K, Inatomi T, Ibata Y, Fuku-hara C, Inouye ST: Differences of somatostatin mRNA in the rat su-prachiasmatic nucleus under light-dark and constant dark conditions: An analysis by in situ hybridization. Neurosci Lett 1995;197:231-234.
26. Fukuhara C, Hamada T, Shibata S, Watanabe S, Aoki K, Inouye SI: Phase advances of circadian rhythms in somatostatin depleted rats: Effects of cysteamine on rhythms of locomotor activity and electrical discharge of the supra-chiasmatic nucleus. J Comp Physiol A 1994;175:677-685.
27. Hamada T, Shibata S, Tsuneyoshi A, Tominaga K, Watanabe S: Effect of somatostatin on circadian rhythms of firing and 2-deoxyglu-cose uptake in rat suprachiasmatic slices. Am J Physiol 1993;265: R1199-R1204.
28. Holoshitz J, Matiau JA, Cohen IR: Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II. J Clin Invest 1984;73:211-215.
29. van Eden W, Holoshitz J, Nevo Z, Frenkel A, Klajman A, Cohen IR: Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci USA 1985;82:5117-5120.
30. Cammisuli S: The effect of cyclosporin A on cell interactions within the immune system; in White DJG (ed): Cyclosporin A. Amsterdam, Elsevier, 1982, pp 243-259.
31. Esquifino AI, Selgas L, Della Maggiore V, Castrillon P, Cardinali DP: Diurnal changes in cyclosporine effect on ornithine decarboxylase and noradrenergic and cholinergic activities in submaxillary lymph nodes. Eur J Pharmacol 1997;319:181-189.